Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | STM-416 |
Trade Name | |
Synonyms | STM 416|STM416 |
Drug Descriptions |
STM-416 is an injectable hydrogel formulation of resiquimod, a TLR7/8 agonist, which potentially enhances antitumor immune response and induces tumor cell lysis (PMID: 39735340, NCI Drug Dictionary). |
DrugClasses | TLR7 Agonist 13 TLR8 Agonist 10 |
CAS Registry Number | NA |
NCIT ID | C201569 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
STM-416 | STM-416 | 0 | 1 |